Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

Del Fabro V.

Writing – Original Draft Preparation

;Markovic U.;Frazzetto S.;Sciortino R.;Bellofiore C.;Di Giorgio M. A.;Leotta V.;Bulla A.;Pelle A. C.;Elia F.;Mannina D.;Consoli U.;Mineo G.;Giallongo C.;Romano A.;Di Raimondo F.;Conticello C.

2024-01-01